Disability and Long COVID

Journal: Advances in Medicine and Engineering Interdisciplinary Research DOI: 10.32629/ameir.v2i2.2037

Daniel Suárez Herández1, Elena Pascual Roquet Jalmar2, Carlos Diego Coll3, Ramón Valdés Carrillo4, Ramon Munera Escolano5

1. Laboral Doctor, Benejúzar Health Centre, Alicante, Spain.
2. General Practitioner, St. Adrian Health Centre, Navarra, Spain.
3. General Practitioner Bigastro Health Centre, Alicante, Spain.
4. Pediatrician La Loma Health Centre, Alicante, Spain.
5. General Practitioner in SAMU Denia, Alicante, Spain.

Abstract

Long COVID may affect 10 to 33 million working-age adults in the United States, and it involves a range of potentially disabling symptoms. There is no standard presentation or treatment for Long COVID, and it is still unclear how long it will last for those affected. The implications of Long COVID for employment and health coverage are not yet well understood. It is also unclear whether vaccines and prior immunity protect against Long COVID. The impact of Long COVID on a worker's return to work can be significant, and occupational medicine physicians should follow best practices in handling the return to work of Long COVID patients.

Keywords

Long COVID; disability; Long COVID symptoms

References

[1] Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post COVID-19 condition or Long COVID: a meta-analysis and systematic review. J Infect Dis, 2022: jiac 136.
[2] Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. Short-term and long-term rates of postacute sequelae of SARSS-CoV-2 infection: a systematic review. JAMA Netw Open, 2021; 4: e2128568.
[3] Hang Q, Zheng B, Daines L, Sheik A. Long term sequelae of COVID-19: a systematic review and meta-analysis of one year follow up studies on post-COVID symptoms. Pathogens, 2022; 11: 269.
[4] Xiong QT, Xu M, Li J, Liu Y, Zhang J, Xu YH, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single centre longitudinal study. Clin Microbiol Infect, 2021; 27; 89-95.
[5] Goertz YMJ, Van Herck m, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res, 2020; 6(4): 542.
[6] Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a crosssectional evaluation. J Med Virol, 2021; 93: 1013-22.
[7] Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6 month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet, 2021; 397: 220-32.
[8] Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. "Long-Covid": a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalization for COVID-19. Thorax, 2021; 76: 396-8.
[9] Ayoubkhani D, Khunnti K, Nanlyan V, Maddox T, Humberstone B, Diamond I, et al. Post covid síndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ, 2021; 372; n693.

Copyright © 2024 Daniel Suárez Herández, Elena Pascual Roquet Jalmar, Carlos Diego Coll, Ramón Valdés Carrillo, Ramon Munera Escolano

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License